Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

[Regulative mechanism of renal inflammatory-related p38MAPK signaling pathway in diabetic nephropathy and interventional effects of Chinese herbal medicine].

Chen HL, Wan YG, Zhao Q, Huang YR, Shi XM, Meng XJ, Yao J.

Zhongguo Zhong Yao Za Zhi. 2013 Jul;38(14):2268-72. Chinese.

PMID:
24199552
2.

Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.

Mao ZM, Shen SM, Wan YG, Sun W, Chen HL, Huang MM, Yang JJ, Wu W, Tang HT, Tang RM.

J Ethnopharmacol. 2015 Sep 15;173:256-65. doi: 10.1016/j.jep.2015.07.036. Epub 2015 Jul 28.

PMID:
26226437
3.
4.

[Effects of huangkui capsule on renal inflammatory injury by intervening p38MAPK signaling pathway in rats with adriamycin-induced nephropathy].

Zhao Q, Wan YG, Sun W, Wang CJ, Wei QX, Chen HL, Meng XJ.

Zhongguo Zhong Yao Za Zhi. 2012 Oct;37(19):2926-34. Chinese.

PMID:
23270236
5.

Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, ameliorates adriamycin-induced renal inflammation and glomerular injury via inhibiting p38MAPK signaling pathway activity in rats.

Tu Y, Sun W, Wan YG, Che XY, Pu HP, Yin XJ, Chen HL, Meng XJ, Huang YR, Shi XM.

J Ethnopharmacol. 2013 May 20;147(2):311-20. doi: 10.1016/j.jep.2013.03.006. Epub 2013 Mar 18.

PMID:
23518420
6.
7.

[Regulatory mechanism of p38MAPK signaling pathway on renal tissue inflammation in chronic kidney disease and interventional effect of traditional Chinese medicine].

Zhao Q, Wan Y, Wang C, Wei Q, Chen H, Meng X, Yao J.

Zhongguo Zhong Yao Za Zhi. 2012 Jun;37(12):1700-4. Review. Chinese.

PMID:
22997808
8.

[Regulative mechanisms of oxidative stress in kidney in diabetic nephropathy and interventional effects of Chinese herbal medicine].

Mao ZM, Huang YR, Wan YG, Chen HL, Shi XM, Meng XJ, Yao J.

Zhongguo Zhong Yao Za Zhi. 2014 Oct;39(19):3707-12. Review. Chinese.

PMID:
25612425
9.

[Regulative mechanisms of mammalian target of rapamycin signaling pathway in glomerular hypertrophy in diabetic nephropathy and interventional effects of Chinese herbal medicine].

Yang JJ, Huang YR, Wan YG, Shen SM, Mao ZM, Wu W, Yao J.

Zhongguo Zhong Yao Za Zhi. 2015 Aug;40(16):3125-31. Review. Chinese.

PMID:
26790279
10.
11.

Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy.

Sakai N, Wada T, Furuichi K, Iwata Y, Yoshimoto K, Kitagawa K, Kokubo S, Kobayashi M, Hara A, Yamahana J, Okumura T, Takasawa K, Takeda S, Yoshimura M, Kida H, Yokoyama H.

Am J Kidney Dis. 2005 Jan;45(1):54-65.

PMID:
15696444
12.

[Effect of supplementing Qi-nourishing Yin-dispersing blood stasis-dredging collateral herbs on p38 MAPK signaling pathway in kidney of early diabetic rats].

Zhao W, Chen Z, Zhang J, Sun Y, Wang Y, Wang H.

Zhongguo Zhong Yao Za Zhi. 2010 Mar;35(6):768-71. Chinese.

PMID:
20545206
13.

[Mechanism of Chinese herbal medicine delaying glomerulosclerosis in diabetic nephropathy].

Chen J, Wan Y, Bian R, Gu L, Wang C, Zhang H, Yao J.

Zhongguo Zhong Yao Za Zhi. 2010 Feb;35(4):525-30. Review. Chinese.

PMID:
20450059
14.

[Regulative mechanism of Chinese herbal medicine on cell signaling pathway in kidney].

Wang C, Wan Y, Luo X, Dou C, Feng Q, Yan Q, Yao J.

Zhongguo Zhong Yao Za Zhi. 2011 Jan;36(1):85-91. Review. Chinese.

PMID:
21473159
15.

Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.

Elmarakby AA, Sullivan JC.

Cardiovasc Ther. 2012 Feb;30(1):49-59. doi: 10.1111/j.1755-5922.2010.00218.x. Epub 2010 Aug 16. Review.

PMID:
20718759
16.

Reno-protective effect of NECA in diabetic nephropathy: implication of IL-18 and ICAM-1.

Elsherbiny NM, Abd El Galil KH, Gabr MM, Al-Gayyar MM, Eissa LA, El-Shishtawy MM.

Eur Cytokine Netw. 2012 Jul-Sep;23(3):78-86. doi: 10.1684/ecn.2012.0309.

17.

Effects of alpha-lipoic acid on transforming growth factor beta1-p38 mitogen-activated protein kinase-fibronectin pathway in diabetic nephropathy.

Lee SJ, Kang JG, Ryu OH, Kim CS, Ihm SH, Choi MG, Yoo HJ, Kim DS, Kim TW.

Metabolism. 2009 May;58(5):616-23. doi: 10.1016/j.metabol.2008.12.006.

PMID:
19375583
18.

Renal p38 MAP kinase activity in experimental diabetes.

Komers R, Lindsley JN, Oyama TT, Cohen DM, Anderson S.

Lab Invest. 2007 Jun;87(6):548-58. Epub 2007 Apr 2.

19.

D-saccharic acid 1,4-lactone protects diabetic rat kidney by ameliorating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via NF-κB and PKC signaling.

Bhattacharya S, Manna P, Gachhui R, Sil PC.

Toxicol Appl Pharmacol. 2013 Feb 15;267(1):16-29. doi: 10.1016/j.taap.2012.12.005. Epub 2012 Dec 19.

PMID:
23261973
20.

[Effects of lovastatin on renal function and expression of phosphorylating-p38 mitogen-activated protein kinase in experimental diabetic nephropathy in rats].

Wang LH, Duan HJ, Shi YH, Liu QJ, He N, Liu SX.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2004 Dec;16(12):734-7. Chinese.

PMID:
15585148

Supplemental Content

Support Center